MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$578,503
EPS
-$0.36
Unit: Dollar

Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-09-30
Income taxes
0 0 NaN NaN
Net revenues
0 0 NaN NaN
Gross profit
0 0 NaN NaN
Marketing expenses
52 8 176 114
General and administrative
306,796 412,023 487,041 564,683
Research and development
29,681 7,482 8,842 206,161
Stock based compensation
50,000 50,000 50,000 37,500
Total operating expenses
386,529 469,513 546,059 808,458
Loss from operations
-386,529 -469,513 -546,059 -808,458
Other income
0 5,797 NaN NaN
Modification of warrants
0 17,505 NaN 24,770
Inducement of preferred shares
0 845,901 NaN NaN
Interest expense
2,024 873 448 850
Interest expense - debt discount
70,211 42,175 27,704 263,719
Interest expense - original issuance costs
119,739 81,017 94,353 99,126
Total other expense
-191,974 -981,674 -122,505 -388,465
Loss before income taxes
-578,503 -1,451,187 -668,564 -1,196,923
Net loss
-578,503 -1,451,187 -668,564 -1,196,923
Basic EPS
-0.36 -0.9 -0.42 -0.94
Diluted EPS
-0.36 -0.9 -0.42 -0.94
Basic Average Shares
1,605,377 1,605,377 1,605,377 1,268,795
Diluted Average Shares
1,605,377 1,605,377 1,605,377 1,268,795
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net loss-$578,503 (51.67%↑ Y/Y)Loss before incometaxes-$578,503 (51.67%↑ Y/Y)Loss from operations-$386,529 (52.19%↑ Y/Y)Total other expense-$191,974 (50.58%↑ Y/Y)Total operatingexpenses$386,529 (-52.19%↓ Y/Y)Interest expense -original issuance costs$119,739 (20.79%↑ Y/Y)Interest expense - debtdiscount$70,211 (-73.38%↓ Y/Y)Interest expense$2,024 (138.12%↑ Y/Y)General andadministrative$306,796 (-45.67%↓ Y/Y)Stock basedcompensation$50,000 (33.33%↑ Y/Y)Research and development$29,681 (-85.60%↓ Y/Y)Marketing expenses$52 (-54.39%↓ Y/Y)

Sigyn Therapeutics, Inc. (SIGY)

Sigyn Therapeutics, Inc. (SIGY)